Lab of @peterRchai focused on technologies to detect and change the human response to disease
Joined March 2020
- Tweets227
- Following23
- Followers102
- Likes32
chailab retweeted
New from our collaboration with Pathology @BrighamWomens @BrighamResearch - we assessed the performance of new generation #fentanyl assays to define their performance in clinical care:
academic.oup.com/jalm/advanc…
chailab retweeted
Coming back from another awesome #acmt2024 where we met our newest cohort of the ANTIDOTE program a r25 with @Dr_Carreiro and @NIDAnews. Awesome meeting Junior faculty toxicologists and hearing from POs at NIDA and NIAAA on k awards
chailab retweeted
Awesome work from our @BostonChildrens @BWHEmergencyMed @Harvard_Tox group on management of severe lead encelopathy #acmt2024
chailab retweeted
On 4/15 (12:30pm ET) @DrTiffanyGlynn presents her #HIV research in progress! @MGHPsychiatry @transSOCIALfl @TMPInc_org @ourtranshealth @FirstEventConf @BHCHP @BWHEmergencyMed @MGHPsychiatry @harvardmed #transwomen #HealthEquity #substanceusedisorders Info@ conta.cc/3vLVQVh
Proud to join colleagues across the world to develop cannabis/cannabinoid guidelines for adults with cancer with @ASCO @DanaFarber @BrighamResearch: ascopubs.org/doi/10.1200/JCO…
chailab retweeted
Smartphone and Wearable Device-Based Digital Phenotyping to Understand Substance use and its Syndemics. READ IT HERE in @JMT_tweets >> rdcu.be/dAqjF
@PeterRchai @harvard_tox @brighamwomens @chai_lab @Dr_Carreiro @FenwayHealth @jslee_phd @k_deux_v
Smartphone and Wearable Device-Based Digital Phenotyping to Understand Substance use and its Syndemics | @acmtmedtox READ IT HERE >> rdcu.be/dAqjF link.springer.com/article/10…
From our lab with @DrTiffanyGlynn @jslee_phd and collaborators @khmayer1 @FenwayHealth @FordhamEthics work in @PLOSDigiHealth on how MSM on #PrEP think about #digitalpills and #digitalphenotyping
journals.plos.org/digitalhea…
One of the most important things we wanted to do here was break down the #stigma barriers that individuals will substance use won't engage in technologies to address comorbid disease. This analysis shows that sub use was not associated with MSM willingness to use #digitalpills
Excited to share our new manuscript on formative usability and acceptability of digital pill systems for #heartfailure #adherence measurement using #digitalpills in @jmirpub
cardio.jmir.org/2024/1/e4897…
Excited to participate with our close colleagues @MIT on the new @ARPA_H initiative to advance our knowledge and treatment of metabolic disease! @BWHEmergencyMed
news.mit.edu/2024/mit-led-te…
Discussing work by @DrTiffanyGlynn on understanding strategies to reach individuals with hiv risk using technologies in the emergency dept @HICSSnews #hicss57
Dr. Lee @jslee_phd presenting on work on #digitalpills and their application in #hiv #adherence monitoring in South Africa. In collaboration with @UCT_news #hicss57 @HICSSnews
Work with our colleagues @FenwayHealth on perspectives of sexual networking of MSM identifying as persons of color during COVID-19
pubmed.ncbi.nlm.nih.gov/3816…
New work from our group led by @Dr_GoldiTox on updates in current management of beta blocker and calcium channel blocker toxicity in European Heart Journal @ESC_Journals: academic.oup.com/ehjacc/adva…
chailab retweeted
Although fentanyl is now the dominant driver of the U.S. opioid epidemic, our health care system has struggled to adapt toxicology screening practices to this reality. Read the Perspective by Drs. @BrianBarnettMD, @PeterRchai & Joji Suzuki: nej.md/3Qyv0HO
chailab retweeted
our perspective on increasing access to #fentanyl testing and increasing access to point of care testing for those with #oud @NEJM nejm.org/doi/full/10.1056/NE…
